<
div data-test=”articleBody”>
Canadian cannabis company announced Thursday it has signed a $ 200 million contract with Super Pharm, controlled by Leon Kupler. Under the contract, Kanduk’s products will be distributed in Super Pharm’s over the next three years.
Kendok, owned Intercure, Will start distributing its products today in 41 of Super Pharm’s licensed pharmacies. As part of the deal, Super Pharm will buy 10 tonnes of cannabis products, the total cost of which is about NIS 200 million.
Intercure stock
Super Pharm now has 260 branches in Israel – from Kiryat Shmona to Eilat in the south. Many cannabis companies in Israel would like to grab a shelf share in Super Pharm’s safe, where the various cannabis products are stored. Today, under the new reform, the power of selecting cannabis products has passed from the exclusive hands of the Medical Cannabis Unit (YCR) to the customers.
Meanwhile, patients are furious about the rise in prices and are awaiting a High Court ruling on this issue.
<
div class=”q aw qk”>
<
div class=”no sn aw g h”><img alt=”US”ר קנדוק, אהוד ברק” src=”https://images.haarets.co.il/image/fetch/w_2448,h_1632,c_crop/q_auto,h_233,w_350,c_fill,f_auto/fl_lossy.any_format.preserve_transparency.progressive:none/https://www.haaretz.co.il/polopoly_fs/1.8553378!/image/967129436.jpg” class=”bi bv t ah g” width=”2448″ height=”1632″ sizes=”(min-width:1280px) 592px,(min-width:1024px) 490px,(min-width:600px) 540px, calc(100vw – 36px)” srcset=”https://images.haarets.co.il/image/fetch/w_2448,h_1632,c_crop/q_auto,h_233,w_350,c_fill,f_auto/fl_lossy.any_format.preserve_transparency.progressive:none/https://www.haaretz.co.il/polopoly_fs/1.8553378!/image/967129436.jpg 350w,https://images.haarets.co.il/image/fetch/w_2448,h_1632,c_crop/q_auto,h_327,w_490,c_fill,f_auto/fl_lossy.any_format.preserve_transparency.progressive:none/https://www.haaretz.co.il/polopoly_fs/1.8553378!/image/967129436.jpg 490w,https://images.haarets.co.il/image/fetch/w_2448,h_1632,c_crop/q_auto,h_400,w_600,c_fill,f_auto/fl_lossy.any_format.preserve_transparency.progressive:none/https://www.haaretz.co.il/polopoly_fs/1.8553378!/image/967129436.jpg 600w,https://images.haarets.co.il/image/fetch/w_2448,h_1632,c_crop/q_auto,h_467,w_700,c_fill,f_auto/fl_lossy.any_format.preserve_transparency.progressive:none/https://www.haaretz.co.il/polopoly_fs/1.8553378!/image/967129436.jpg 700w,https://images.haarets.co.il/image/fetch/w_2448,h_1632,c_crop/q_auto,h_683,w_1024,c_fill,f_auto/fl_lossy.any_format.preserve_transparency.progressive:none/https://www.haaretz.co.il/polopoly_fs/1.8553378!/image/967129436.jpg 1024w,https://images.haarets.co.il/image/fetch/w_2448,h_1632,c_crop/q_auto,h_800,w_1200,c_fill,f_auto/fl_lossy.any_format.preserve_transparency.progressive:none/https://www.haaretz.co.il/polopoly_fs/1.8553378!/image/967129436.jpg 1200w” data-test=”articleBodyImage”/>
